Vinícius Silva Belo

Dr. Vinícius Silva Belo

Federal University of São João del-Rei, Divinópolis, Minas Gerais, Brazil
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2013 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo
GWGuilherme Loureiro Werneck
Guilherme Loureiro Werneck
DBDavid Soeiro Barbosa
David Soeiro Barbosa
TSTaynãna César Simões
Taynãna César Simões
BNBruno Warlley Leandro Nascimento
Bruno Warlley Leandro Nascimento
CSCláudio José Struchiner
Cláudio José Struchiner
Author Summary Visceral leishmaniasis (VL) is the most severe clinical form of leishmaniasis. In the Americas, VL is a zoonosis caused by the protozoan parasite Leishmania infantum , an intracellular micro-organism transmitted to humans through the bite of female phlebotomine sand flies. The domestic dog is considered the main reservoir and human beings are dead-end hosts. The disease occurs in 12 countries of the New World and Brazil accounts for 90% of the reported cases. The factors associated with infection are only partially understood, making harder understanding the disease dynamics and the development of effective and well-targeted control measures. Our work is the first systematic review with meta-analysis about factors associated with human visceral leishmaniasis in the Americas. It provides an organization of the available information, the description of more accurate data on the role of each of the factors studied, the evaluation of possible causes of heterogeneity in the results of the studies as well as the analysis of the quality of publications and limitations in the existing knowledge. The results of this study might be useful in the definition of which and where target interventions should be delivered, and for guiding researchers towards the development of future studies of better methodological quality.

24 July 2014 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo
CSCláudio José Struchiner
Cláudio José Struchiner
DBDavid Soeiro Barbosa
David Soeiro Barbosa
BNBruno Warlley Leandro Nascimento
Bruno Warlley Leandro Nascimento
MHMarco Aurélio Pereira Horta
Marco Aurélio Pereira Horta
GWGuilherme Loureiro Werneck
Guilherme Loureiro Werneck
In the current context of high fatality rates associated with American visceral leishmaniasis (VL), the appropriate use of prognostic factors to identify patients at higher risk of unfavorable outcomes represents a potential tool for clinical practice. This systematic review brings together information reported in studies conducted in Latin America, on the potential predictors of adverse prognosis (continued evolution of the initial clinical conditions of the patient despite the implementation of treatment, independent of the occurrence of death) and death from VL. The limitations of the existing knowledge, the advances achieved and the approaches to be used in future research are presented. The full texts of 14 studies conforming to the inclusion criteria were analyzed and their methodological quality examined by means of a tool developed in the light of current research tools. Information regarding prognostic variables was synthesized using meta-analysis. Variables were grouped according to the strength of evidence considering summary measures, patterns and heterogeneity of effect-sizes, and the results of multivariate analyses. The strongest predictors identified in this review were jaundice, thrombocytopenia, hemorrhage, HIV coinfection, diarrhea, age 40–50 years, severe neutropenia, dyspnoea and bacterial infections. Edema and low hemoglobin concentration were also associated with unfavorable outcomes. The main limitation identified was the absence of validation procedures for the few prognostic models developed so far. Integration of the results from different investigations conducted over the last 10 years enabled the identification of consistent prognostic variables that could be useful in recognizing and handling VL patients at higher risk of unfavorable outcomes. The development of externally validated prognostic models must be prioritized in future investigations. In contrast to other clinical presentations of leishmaniasis in Latin America, American visceral leishmaniasis (VL) can lead to death in 5-10% of patients under treatment. The fatality rates associated with this disease have remained stable at a high level over the years in Brazil and are neither recorded in under-treatment patients from endemic countries of the Old World nor from non-endemic countries where such cases are imported. Since VL-induced lethality can occur even after the implementation of recommended therapy, the understanding of individual, clinical and laboratory factors that predispose to an unfavorable outcome might represent an important feature for informing better practice in the clinical management of cases. The present systematic review with meta-analysis brings together information on various prognostic variables associated with the severity of VL. Potential predictors identified in the studies surveyed were grouped according to the strength of evidence available, and 13 were considered to be of significant relevance. The gaps in the existing knowledge and the need for the development of externally validated prognostic models were also discussed. The results presented herein could be useful in identifying patients at higher risk of unfavorable evolution or death from VL, and might provide an aid in decision-making regarding the clinical management of VL cases.

1 July 2013 in Veterinary Parasitology
Verified
Journal Article
Closed access
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo
CSCláudio José Struchiner
Cláudio José Struchiner
GWGuilherme Loureiro Werneck
Guilherme Loureiro Werneck
DBDavid Soeiro Barbosa
David Soeiro Barbosa
RORobson Bruniera de Oliveira
Robson Bruniera de Oliveira
ESEduardo Sérgio da Silva
Eduardo Sérgio da Silva

15 May 2023 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
ÁSÁlisson Oliveira dos Santos
Álisson Oliveira dos Santos
EDUARDO SERGIO DA Sergio da SILVAEDUARDO SERGIO DA Sergio da SILVA
EDUARDO SERGIO DA Sergio da SILVA
LCLetícia Machado Couto
Letícia Machado Couto
GRGustavo Valadares Labanca Reis
Gustavo Valadares Labanca Reis
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo

1 April 2021 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
BMBrayan Jonas Mano-Sousa
Brayan Jonas Mano-Sousa
APAlessandra Moraes Pedrosa
Alessandra Moraes Pedrosa
BABruna Cristina Alves
Bruna Cristina Alves
JGJosé Carlos Fernandes Galduróz
José Carlos Fernandes Galduróz
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo
JFJoaquim Mauricio Duarte-Almeida lab. Farmacognosia
Joaquim Mauricio Duarte-Almeida lab. Farmacognosia
There are several studies investigating the effects of risperidone on autism, but many of these studies are contradictory or inconclusive. This systematic review and meta-analysis investigated the effects of risperidone on five domains of the Aberrant Behaviour Checklist (ABC) scale on Autism Spectrum Disorder (ASD), as well as weight gain and waist circumference. The protocol for the present systematic review and meta-analysis was registered on the International Prospective Register of Systematic Reviews (PROSPERO). For this study, we analysed articles (2,459), selecting them according to the PICOS strategy (Population, Intervention, Comparison, Outcome, Study design). Although risperidone is effective for the treatment of lethargy and inadequate speech, concerns about the association between weight gain, waist circumference and risperidone require a need for evaluation of the risk-benefit ratio in its use. There was a significant association between weight gain, waist circumference and risperidone. In conclusion, it was possible to suggest the efficacy of risperidone for the treatment of lethargy and inadequate speech. Finally, we emphasize that the risk-benefit in its use should be evaluated (Protocol number CRD42019122316).

16 December 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Vinícius Silva BeloVinícius Silva Belo
Vinícius Silva Belo
GWGuilherme Loureiro Werneck
Guilherme Loureiro Werneck
ESEduardo Sérgio da Silva
Eduardo Sérgio da Silva
DBDavid Soeiro Barbosa
David Soeiro Barbosa
CSCláudio José Struchiner
Cláudio José Struchiner
The understanding of the structure of free-roaming dog populations is of extreme importance for the planning and monitoring of populational control strategies and animal welfare. The methods used to estimate the abundance of this group of dogs are more complex than the ones used with domiciled owned dogs. In this systematic review, we analyze the techniques and the results obtained in studies that seek to estimate the size of free-ranging dog populations. Twenty-six studies were reviewed regarding the quality of execution and their capacity to generate valid estimates. Seven of the eight publications that take a simple count of the animal population did not consider the different probabilities of animal detection; only one study used methods based on distances; twelve relied on capture-recapture models for closed populations without considering heterogeneities in capture probabilities; six studies applied their own methods with different potential and limitations. Potential sources of bias in the studies were related to the inadequate description or implementation of animal capturing or viewing procedures and to inadequacies in the identification and registration of dogs. Thus, there was a predominance of estimates with low validity. Abundance and density estimates carried high variability, and all studies identified a greater number of male dogs. We point to enhancements necessary for the implementation of future studies and to potential updates and revisions to the recommendations of the World Health Organization with respect to the estimation of free-ranging dog populations.